Skip to main content
Clinical Trials/NCT00948974
NCT00948974
Completed
Not Applicable

Variations of Cognitive Behavior Therapy for Social Anxiety Disorder

Drexel University1 site in 1 country88 target enrollmentJanuary 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Social Anxiety Disorder
Sponsor
Drexel University
Enrollment
88
Locations
1
Primary Endpoint
Social Phobia and Anxiety Inventory (SPAI) - Social Phobia Subscale
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to compare the efficacy of two variants of cognitive behavioral therapy (CBT) (cognitive therapy (CT) and acceptance and commitment therapy (ACT)), for the treatment of generalized social anxiety disorder.

Detailed Description

We are recruiting a clinical sample of patients who meet diagnostic criteria (per DSM-5) for the generalized subtype of social anxiety disorder. Participants are randomly assigned to the two active intervention conditions; no placebo or sham treatments will be employed. Assessments take place at baseline, pre-treatment, mid-treatment, post-treatment, and at 3- and 12-months follow-up; participants also complete a brief weekly assessment of functioning. Treatment is administered individually by trained graduate students in clinical psychology, directly trained and supervised by the PI and Co-PI. Participants receive 12 weekly 1-hour long sessions. The study design is a 2 (treatment condition) by 5 (assessment occasion) mixed factorial design.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
December 2015
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

James Herbert

Investigator

Drexel University

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosable social anxiety disorder (generalized subtype per DSM-IV-TR criteria)
  • aged 18-65
  • working fluency in English
  • residence in the greater Philadelphia area.

Exclusion Criteria

  • Pervasive developmental disability
  • acute suicide potential
  • inability to travel to the treatment site
  • schizophrenia or other psychotic disorder
  • current substance dependence
  • Comorbid diagnoses of Major Depressive or other mood or anxiety disorders are acceptable ONLY if clearly secondary to the diagnosis of social anxiety disorder.

Outcomes

Primary Outcomes

Social Phobia and Anxiety Inventory (SPAI) - Social Phobia Subscale

Time Frame: baseline (pre-treatment; immediately prior to beginning treatment); post-treatment (12 weeks)

The SPAI social phobia assess symptoms of social anxiety in the presence of (a) strangers, (b) authority figures, (c) members of the opposite sex, and (d) people in general. The subscale ranges from 32 to 192, where higher scores reflect more severe symptoms of social anxiety.

Secondary Outcomes

  • Outcomes Questionnaire(baseline (pre-treatment; just before beginning treatment); post-treatment (12 weeks))
  • Behavioral Assessment Test(baseline (pre-treatment; just prior to beginning treatment); post-treatment (12 weeks))

Study Sites (1)

Loading locations...

Similar Trials